These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 10914731

  • 1. Tumor irradiation enhances the tumor-specific distribution of poly(L-glutamic acid)-conjugated paclitaxel and its antitumor efficacy.
    Li C, Ke S, Wu QP, Tansey W, Hunter N, Buchmiller LM, Milas L, Charnsangavej C, Wallace S.
    Clin Cancer Res; 2000 Jul; 6(7):2829-34. PubMed ID: 10914731
    [Abstract] [Full Text] [Related]

  • 2. Antitumor activity of poly(L-glutamic acid)-paclitaxel on syngeneic and xenografted tumors.
    Li C, Price JE, Milas L, Hunter NR, Ke S, Yu DF, Charnsangavej C, Wallace S.
    Clin Cancer Res; 1999 Apr; 5(4):891-7. PubMed ID: 10213226
    [Abstract] [Full Text] [Related]

  • 3. Biodistribution of paclitaxel and poly(L-glutamic acid)-paclitaxel conjugate in mice with ovarian OCa-1 tumor.
    Li C, Newman RA, Wu QP, Ke S, Chen W, Hutto T, Kan Z, Brannan MD, Charnsangavej C, Wallace S.
    Cancer Chemother Pharmacol; 2000 Apr; 46(5):416-22. PubMed ID: 11127947
    [Abstract] [Full Text] [Related]

  • 4. Complete regression of well-established tumors using a novel water-soluble poly(L-glutamic acid)-paclitaxel conjugate.
    Li C, Yu DF, Newman RA, Cabral F, Stephens LC, Hunter N, Milas L, Wallace S.
    Cancer Res; 1998 Jun 01; 58(11):2404-9. PubMed ID: 9622081
    [Abstract] [Full Text] [Related]

  • 5. Poly(L-glutamic acid)-paclitaxel conjugate is a potent enhancer of tumor radiocurability.
    Milas L, Mason KA, Hunter N, Li C, Wallace S.
    Int J Radiat Oncol Biol Phys; 2003 Mar 01; 55(3):707-12. PubMed ID: 12573758
    [Abstract] [Full Text] [Related]

  • 6. Potentiation of ovarian OCa-1 tumor radioresponse by poly (L-glutamic acid)-paclitaxel conjugate.
    Li C, Ke S, Wu QP, Tansey W, Hunter N, Buchmiller LM, Milas L, Charnsangavej C, Wallace S.
    Int J Radiat Oncol Biol Phys; 2000 Nov 01; 48(4):1119-26. PubMed ID: 11072171
    [Abstract] [Full Text] [Related]

  • 7. Comparison of action of paclitaxel and poly(L-glutamic acid)-paclitaxel conjugate in human breast cancer cells.
    Oldham EA, Li C, Ke S, Wallace S, Huang P.
    Int J Oncol; 2000 Jan 01; 16(1):125-32. PubMed ID: 10601557
    [Abstract] [Full Text] [Related]

  • 8. Potentiation of radioresponse by polymer-drug conjugates.
    Ke S, Milas L, Charnsangavej C, Wallace S, Li C.
    J Control Release; 2001 Jul 06; 74(1-3):237-42. PubMed ID: 11489500
    [Abstract] [Full Text] [Related]

  • 9. 130-nm albumin-bound paclitaxel enhances tumor radiocurability and therapeutic gain.
    Wiedenmann N, Valdecanas D, Hunter N, Hyde S, Buchholz TA, Milas L, Mason KA.
    Clin Cancer Res; 2007 Mar 15; 13(6):1868-74. PubMed ID: 17363543
    [Abstract] [Full Text] [Related]

  • 10. Antitumor activity of hydrophilic Paclitaxel copolymer prodrug using locoregional delivery in human orthotopic non-small cell lung cancer xenograft models.
    Zou Y, Fu H, Ghosh S, Farquhar D, Klostergaard J.
    Clin Cancer Res; 2004 Nov 01; 10(21):7382-91. PubMed ID: 15534115
    [Abstract] [Full Text] [Related]

  • 11. Antivascular therapy for orthotopic human ovarian carcinoma through blockade of the vascular endothelial growth factor and epidermal growth factor receptors.
    Thaker PH, Yazici S, Nilsson MB, Yokoi K, Tsan RZ, He J, Kim SJ, Fidler IJ, Sood AK.
    Clin Cancer Res; 2005 Jul 01; 11(13):4923-33. PubMed ID: 16000591
    [Abstract] [Full Text] [Related]

  • 12. Antitumor activity of 4-(N-hydroxyphenyl)retinamide conjugated with poly(L-glutamic acid) against ovarian cancer xenografts.
    Zou C, Brewer M, Cao X, Zang R, Lin J, Deng Y, Li C.
    Gynecol Oncol; 2007 Dec 01; 107(3):441-9. PubMed ID: 17854871
    [Abstract] [Full Text] [Related]

  • 13. Superior therapeutic profile of poly-L-glutamic acid-paclitaxel copolymer compared with taxol in xenogeneic compartmental models of human ovarian carcinoma.
    Auzenne E, Donato NJ, Li C, Leroux E, Price RE, Farquhar D, Klostergaard J.
    Clin Cancer Res; 2002 Feb 01; 8(2):573-81. PubMed ID: 11839679
    [Abstract] [Full Text] [Related]

  • 14. Paclitaxel and water-soluble poly (L-glutamic acid)-paclitaxel, induce direct chromosomal abnormalities and cell death in a murine metastatic melanoma cell line.
    Multani AS, Li C, Ozen M, Yadav M, Yu DF, Wallace S, Pathak S.
    Anticancer Res; 1997 Feb 01; 17(6D):4269-74. PubMed ID: 9494519
    [Abstract] [Full Text] [Related]

  • 15. Therapeutic targeting of the endothelin a receptor in human ovarian carcinoma.
    Rosanò L, Spinella F, Salani D, Di Castro V, Venuti A, Nicotra MR, Natali PG, Bagnato A.
    Cancer Res; 2003 May 15; 63(10):2447-53. PubMed ID: 12750265
    [Abstract] [Full Text] [Related]

  • 16. Flavopiridol increases therapeutic ratio of radiotherapy by preferentially enhancing tumor radioresponse.
    Mason KA, Hunter NR, Raju U, Ariga H, Husain A, Valdecanas D, Neal R, Ang KK, Milas L.
    Int J Radiat Oncol Biol Phys; 2004 Jul 15; 59(4):1181-9. PubMed ID: 15234054
    [Abstract] [Full Text] [Related]

  • 17. Anti-Vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions.
    Lee CG, Heijn M, di Tomaso E, Griffon-Etienne G, Ancukiewicz M, Koike C, Park KR, Ferrara N, Jain RK, Suit HD, Boucher Y.
    Cancer Res; 2000 Oct 01; 60(19):5565-70. PubMed ID: 11034104
    [Abstract] [Full Text] [Related]

  • 18. [Combination chemotherapy of paclitaxel followed by nedaplatin for human ovarian cancer].
    Uchida N, Yamada H, Maekawa R, Yoshioka T.
    Gan To Kagaku Ryoho; 2002 Nov 01; 29(11):1943-9. PubMed ID: 12465394
    [Abstract] [Full Text] [Related]

  • 19. Enhancement of tumor radioresponse of a murine mammary carcinoma by paclitaxel.
    Milas L, Hunter NR, Mason KA, Kurdoglu B, Peters LJ.
    Cancer Res; 1994 Jul 01; 54(13):3506-10. PubMed ID: 7912167
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics of oxaliplatin (NSC 266046) alone and in combination with paclitaxel in cancer patients.
    Liu J, Kraut E, Bender J, Brooks R, Balcerzak S, Grever M, Stanley H, D'Ambrosio S, Gibson-D'Ambrosio R, Chan KK.
    Cancer Chemother Pharmacol; 2002 May 01; 49(5):367-74. PubMed ID: 11976830
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.